Department of Clinical Microbiology, University College London Hospitals, 46 Cleveland Street, London W1T 4JF, UK.
J Antimicrob Chemother. 2012 Jul;67 Suppl 1:i23-8. doi: 10.1093/jac/dks198.
Surveillance and feedback of results to clinical teams is central to performance improvement in managing healthcare-acquired infections. A major role of the Advisory Committee on Antimicrobial Resistance and Healthcare-Associated Infections (ARHAI) is to advise on surveillance priorities. A sub-committee was set up to systematically review existing UK surveillance schemes. The following three systems were examined in detail: mandatory reporting of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia and Clostridium difficile infection to the HPA; surveillance of surgical site infection undertaken by the HPA; and surgical site infection surveillance undertaken at University College London Hospital. Recommendations included the extension of mandatory reporting to include bacteraemia due to Escherichia coli and methicillin-susceptible S. aureus (MSSA), post-discharge surveillance of surgical site infection, the need for validation of surveillance systems and mandatory reporting of Caesarean section wound infections. Mandatory reporting of bacteraemia due to E. coli and MSSA were introduced during 2011 and further extension of surveillance is likely.
监测和向临床团队反馈结果是改善医疗保健相关感染管理绩效的核心。抗菌药物耐药性和医疗保健相关感染咨询委员会（ARHAI）的主要作用是就监测重点提供建议。成立了一个小组委员会，对现有的英国监测计划进行系统审查。详细审查了以下三个系统：向 HPA 强制报告耐甲氧西林金黄色葡萄球菌（MRSA）菌血症和艰难梭菌感染；HPA 进行的手术部位感染监测；以及伦敦大学学院医院进行的手术部位感染监测。建议包括将强制性报告扩展到包括大肠杆菌和甲氧西林敏感金黄色葡萄球菌（MSSA）引起的菌血症、手术后手术部位感染的监测、监测系统验证的必要性以及剖宫产伤口感染的强制性报告。2011 年引入了大肠杆菌和 MSSA 菌血症的强制性报告，并且可能会进一步扩展监测范围。
